Trials / Recruiting
RecruitingNCT06389552
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
A Long-term Follow-up Study of FOLFIRINOX Regimen as Adjuvant Therapy in Pancreatic Cancer Patients After Curative Surgery: Multi-center, Prospective
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (estimated)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.
Detailed description
This study is multi-center, prospective, long-term follow-up observational study.
Conditions
Timeline
- Start date
- 2023-09-25
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2024-04-29
- Last updated
- 2024-04-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06389552. Inclusion in this directory is not an endorsement.